ImageneBio, Inc. (IMA) Operating cash flow 2020–2025
ImageneBio, Inc. (IMA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$47.8MFY2025 · since FY2020: -$37.8M → -$47.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$47.8M | -124.4% |
| FY2024 | -$21.3M | +73.3% |
| FY2023 | -$79.7M | -7.6% |
| FY2022 | -$74.1M | -23.0% |
| FY2021 | -$60.3M | -59.3% |
| FY2020 | -$37.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice